Fresenius SE & Co. KGaA Share Price Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 22.19B 24.12B 2,008B | Sales 2025 * | 23.33B 25.36B 2,112B | Capitalization | 15.63B 16.99B 1,415B |
---|---|---|---|---|---|
Net income 2024 * | 1.41B 1.54B 128B | Net income 2025 * | 1.74B 1.89B 157B | EV / Sales 2024 * | 1.26 x |
Net Debt 2024 * | 12.44B 13.52B 1,126B | Net Debt 2025 * | 11.7B 12.72B 1,059B | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
11.2
x | P/E ratio 2025 * |
8.89
x | Employees | - |
Yield 2024 * |
3.41% | Yield 2025 * |
3.75% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12/21/12 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01/19/01 |
Michael Moser
CMP | Compliance Officer | - | 18/23/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20/15/20 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01/20/01 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 16/07/16 |
1st Jan change | Capi. | |
---|---|---|
+20.09% | 85.14B | |
-27.30% | 72.06B | |
+2.89% | 27.07B | |
-9.00% | 17.43B | |
+4.56% | 16.02B | |
+69.72% | 13.06B | |
+4.14% | 12.9B | |
+73.30% | 12.79B | |
+34.53% | 12.36B |